Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension: A Basis for Excessive Cell Proliferation and a New Therapeutic Target

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Circulation

• Publication date

  2010-06-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.109.916098PMID 20529999PMCID PMC2914302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations.

  2008cited by this paper
• Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.

  2008cited by this paper
• Manganese superoxide dismutase modulates hypoxia-inducible factor-1 alpha induction via superoxide.

  2008cited by this paper
• Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells.

  2008cited by this paper
• The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production

  2007cited by this paper
• Chemoprevention of Carcinogenic Progression to Esophageal Adenocarcinoma by the Manganese Superoxide Dismutase Supplementation

  2007cited by this paper
• Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines

  2007cited by this paper
• A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

  2007cited by this paper
• Integrated molecular profiling of SOD2 expression in multiple myeloma.

  2007cited by this paper
• Microvascular regeneration in established pulmonary hypertension by angiogenic gene transfer.

  2006cited by this paper
• HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

  2006cited by this paper
• Acute oxygen-sensing mechanisms.

  2006cited by this paper
• An Abnormal Mitochondrial–Hypoxia Inducible Factor-1&agr;–Kv Channel Pathway Disrupts Oxygen Sensing and Triggers Pulmonary Arterial Hypertension in Fawn Hooded Rats: Similarities to Human Pulmonary Arterial Hypertension

  2006cited by this paper
• Eukaryotic cytosine methyltransferases.

  2005cited by this paper
• Acute oxygen-sensing mechanisms.

  2005cited by this paper
• DNA methylation in epigenetic control of gene expression.

  2005cited by this paper
• Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis.

  2005cited by this paper
• Manganese superoxide dismutase is increased in the airways of smokers' lungs

  2004cited by this paper
• Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators*

  2004cited by this paper
• Reversible Modulation of Cell Cycle Kinetics in NIH/3T3 Mouse Fibroblasts by Inducible Overexpression of Mitochondrial Manganese Superoxide Dismutase

  2004cited by this paper
• Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in pulmonary artery smooth muscle cells

  2004cited by this paper
• Oxidative stress in severe pulmonary hypertension.

  2004cited by this paper
• The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats

  2004cited by this paper
• Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging.

  2003cited by this paper
• An Essential Role for DNA Methyltransferase DNMT3B in Cancer Cell Survival*

  2002cited by this paper
• Dnmt3a and Dnmt3b Are Transcriptional Repressors That Exhibit Unique Localization Properties to Heterochromatin*

  2001cited by this paper
• Chronic hypoxia decreases K(V) channel expression and function in pulmonary artery myocytes.

  2001cited by this paper
• Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension.

  2001cited by this paper
• Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis

  2001cited by this paper
• Mitochondrial or cytosolic catalase reverses the MnSOD-dependent inhibition of proliferation by enhancing respiratory chain activity, net ATP production, and decreasing the steady state levels of H(2)O(2).

  2000cited by this paper
• The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.

  1999cited by this paper
• Decreased Expression of Manganese Superoxide Dismutase in Transformed Cells Is Associated with Increased Cytosine Methylation of the SOD2 Gene

  1999cited by this paper
• Primary pulmonary hypertension between inflammation and cancer.

  1998cited by this paper
• Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype

  1998cited by this paper
• Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit*

  1996cited by this paper
• Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1.

  1995cited by this paper
• CpG methylation represses the activity of the rat prolactin promoter in rat GH3 pituitary cell lines.

  1995cited by this paper
• SOD2: A new type of tumor‐suppressor gene?

  1992cited by this paper
• Mechanism of action of eukaryotic DNA methyltransferase. Use of 5-azacytosine-containing DNA.

  1982cited by this paper

• Multiomics Integration for Identifying Treatment Targets, Drug Development, and Diagnostic Designs in PAH

  2025cites this paper
• Germline and somatic variants in DNMT3A and other clonal haematopoiesis of indeterminate potential genes contribute to pulmonary arterial hypertension.

  2025cites this paper
• Tet Methylcytosine Dioxygenase 2 ( TET2 ) Mutation Drives a Global Hypermethylation Signature in Patients With Pulmonary Arterial Hypertension (PAH): Correlation With Altered Gene Expression Relevant to a Common T Cell Phenotype

  2025cites this paper
• Longitudinal TyG–BMI trajectories predict carotid atherosclerosis progression in a Chinese retrospective cohort

  2025cites this paper
• Mitochondrial fission produces a Warburg effect via the oxidative inhibition of prolyl hydroxylase domain-2

  2025cites this paper
• An Artificial Peroxynitrite-Resistant Superoxide Dismutase for Acute Kidney Injury Alleviation.

  2025cites this paper
• Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series)

  2025cites this paper
• Therapeutic targets for pulmonary arterial hypertension: insights into the emerging landscape

  2025cites this paper
• The uteroplacental circulation at high altitude: adaptation and maladaptation.

  2025cites this paper
• IPSC‐Derived Conditioned Medium Reduces Oxidative Stress and Vascular Remodeling in Rat Models of Pulmonary Arterial Hypertension

  2025cites this paper
• The role of lactate metabolism and lactylation in pulmonary arterial hypertension

  2025cites this paper
• PAH-former: Transfer Learning for Efficient Discovery of Pulmonary Arterial Hypertension-Associated Genes

  2025cites this paper
• Rewriting the vascular script: epigenetic modifiers as scribes of metabolic reprogramming in pulmonary hypertension

  2025cites this paper
• Challenges and opportunities in targeting epigenetic mechanisms for pulmonary arterial hypertension treatment.

  2025cites this paper
• Macrophage plasticity and glucose metabolism: the role of immunometabolism in pulmonary arterial hypertension

  2025cites this paper
• CES1 Deficiency is Associated with Metabolic Reprograming and Endothelial Dysfunction in Pulmonary Arterial Hypertension

  2025cites this paper
• Unraveling the role of HIF and epigenetic regulation in pulmonary arterial hypertension: implications for clinical research and its therapeutic approach

  2024cites this paper
• GPS2 ameliorates cigarette smoking-induced pulmonary vascular remodeling by modulating the ras-Raf-ERK axis

  2024cites this paper
• SOD2 orchestrates redox homeostasis in intervertebral discs: A novel insight into oxidative stress-mediated degeneration and therapeutic potential

  2024cites this paper
• Assessing causal associations of blood counts and biochemical indicators with pulmonary arterial hypertension: a Mendelian randomization study and results from national health and nutrition examination survey 2003–2018

  2024cites this paper
• Metabolic memory: mechanisms and diseases

  2024cites this paper
• Alterations in Mitochondrial Function in Pulmonary Vascular Diseases

  2024cites this paper
• The Aging Heart in Focus: The Advanced Understanding of Heart Failure with Preserved Ejection Fraction.

  2024cites this paper
• Role of EZH2-mediated epigenetic modification on vascular smooth muscle in cardiovascular diseases: A mini-review

  2024cites this paper
• Mechanisms and treatment of pulmonary arterial hypertension

  2024cites this paper
• Mitochondria as a primary determinant of angiogenic modality in pulmonary arterial hypertension

  2024cites this paper
• Hypoxic Pulmonary Vasoconstriction: An Important Component of the Homeostatic Oxygen Sensing System.

  2024cites this paper
• Novel Drp1 GTPase Inhibitor, Drpitor1a: Efficacy in Pulmonary Hypertension

  2024cites this paper
• Emerging Epigenetic Targets and Their Molecular Impact on Vascular Remodeling in Pulmonary Hypertension

  2024cites this paper
• Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

  2024influential citation
• Exploring the pathogenesis of pulmonary vascular disease

  2024cites this paper
• Histone Methyl Transferase G9a/GLP—A Novel Avenue in Pulmonary Arterial Hypertension Treatment?

  2023cites this paper
• lncRNA-TCONS_00008552 expression in patients with pulmonary arterial hypertension due to congenital heart disease

  2023cites this paper
• SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension.

  2023cites this paper
• Pulmonary hypertension: modern methods of treatment and ways of their long-term development.

  2023cites this paper
• Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension

  2023influential citation
• TET2 confers a mechanistic link of microRNA‐210 and mtROS in hypoxia‐suppressed spontaneous transient outward currents in uterine arteries of pregnant sheep

  2023cites this paper
• Prostacyclin mimetics inhibit DRP1-mediated pro-proliferative mitochondrial fragmentation in pulmonary arterial hypertension.

  2023cites this paper
• Distinctive Signs of Disease as Deterrents for the Endothelial Function: A Systematic Review

  2023cites this paper
• Mitochondrial Homeostasis in VSMCs as a Central Hub in Vascular Remodeling

  2023cites this paper
• Switch-Independent 3A: An Epigenetic Regulator in Cancer with New Implications for Pulmonary Arterial Hypertension

  2023cites this paper
• Mitochondrial hyperfusion induces metabolic remodeling in lung endothelial cells by modifying the activities of electron transport chain complexes I and III.

  2023cites this paper
• Diagnostic Value of Serum Galectin-3 Binding Protein Level in Patients with Pulmonary Arterial Hypertension.

  2023cites this paper
• Mitochondria in hypoxic pulmonary hypertension, roles and the potential targets

  2023cites this paper
• Mitochondrial Dynamics in Pulmonary Hypertension

  2023cites this paper
• Efficacy of Drpitor1a, a Dynamin-Related Protein 1 inhibitor, in Pulmonary Arterial Hypertension

  2023cites this paper
• Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development

  2023cites this paper
• Hypoxia and panvascular diseases: exploring the role of hypoxia-inducible factors in vascular smooth muscle cells under panvascular pathologies.

  2023cites this paper
• Superoxide-Mediated Upregulation of MMP9 Participates in BMPR2 Destabilization and Pulmonary Hypertension Development

  2023cites this paper
• Sirtuin 2 deficiency aggravates ageing-induced vascular remodelling in humans and mice

  2023cites this paper
• Epigenetics mechanism and therapeutic potential of approved epi-drugs in pulmonary hypertension disease.

  2023cites this paper
• Cyclin D-CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation

  2023influential citation
• Pathophysiology and new advances in pulmonary hypertension

  2023cites this paper
• Metabolic reprogramming, oxidative stress, and pulmonary hypertension

  2023cites this paper
• The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases

  2023influential citation
• MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment

  2023cites this paper
• G9a/GLP Targeting Ameliorates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.

  2023cites this paper
• Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension.

  2023cites this paper
• Mediterranean G6PD variant mitigates expression of DNA methyltransferases and right heart pressure in experimental model of pulmonary hypertension

  2022cites this paper
• Molecular Pathways in Pulmonary Arterial Hypertension

  2022cites this paper
• Integrating Epigenetics and Metabolomics to Advance Treatments for Pulmonary Arterial Hypertension.

  2022cites this paper
• Differences in the expression of DNA methyltransferases and demethylases in leukocytes and the severity of pulmonary arterial hypertension between ethnic groups

  2022cites this paper
• Reviewing the suitability of mitochondrial transplantation as therapeutic approach for pulmonary hypertension in the era of personalised medicine.

  2022cites this paper
• Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling

  2022cites this paper
• Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension

  2022influential citation
• The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure

  2022cites this paper
• Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension

  2022cites this paper
• Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension

  2022cites this paper
• Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension

  2022cites this paper
• Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling

  2022cites this paper
• Stem cell therapy for pulmonary arterial hypertension: An update.

  2022cites this paper
• Metabolic reprogramming: A novel metabolic model for pulmonary hypertension

  2022cites this paper
• Xinmai 'an extract enhances the efficacy of sildenafil in the treatment of pulmonary arterial hypertension via inhibiting MAPK signalling pathway

  2021cites this paper
• Advance Publication Experimental Animals

  2021cites this paper
• Dipeptidyl peptidase-4 inhibition prevents lung injury in mice under chronic stress via the modulation of oxidative stress and inflammation

  2021cites this paper
• FGF21 attenuates hypoxia-induced dysfunction and inflammation in HPAECs via the microRNA-27b-mediated PPARγ pathway

  2021cites this paper
• Comparative Transcriptional Analysis of Pulmonary Arterial Hypertension Associated With Three Different Diseases

  2021cites this paper
• Identifying Potential Mutations Responsible for Cases of Pulmonary Arterial Hypertension

  2021cites this paper
• Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension

  2021cites this paper
• Superoxide Dismutase 2 (SOD2) in Vascular Calcification: A Focus on Vascular Smooth Muscle Cells, Calcification Pathogenesis, and Therapeutic Strategies

  2021cites this paper
• Hypoxia and the integrated stress response promote pulmonary hypertension and preeclampsia: implications in drug development.

  2021cites this paper
• Characteristics and risk factors of pulmonary hypertension in patients with hyperthyroidism.

  2021cites this paper
• Redox Regulation, Oxidative Stress, and Inflammation in Group 3 Pulmonary Hypertension.

  2021cites this paper
• Genetic Delivery and Gene Therapy in Pulmonary Hypertension

  2021cites this paper
• Integrative Omics to Characterize and Classify Pulmonary Vascular Disease.

  2021cites this paper
• Metabolism in Pulmonary Hypertension.

  2021cites this paper
• TACG_A_260755 113..124

  2021cites this paper
• Effects of chronic moderate alcohol consumption on right ventricle and pulmonary remodelling

  2021cites this paper
• Targeting Molecular and Cellular Mechanisms of Pulmonary Arterial Hypertension

  2021cites this paper
• Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension

  2021cites this paper
• The role of immune cells in pulmonary hypertension: Focusing on macrophages.

  2021cites this paper
• RNA Methylation: A New Regulator of Vascular Remodeling in Pulmonary Hypertension

  2021cites this paper
• Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension

  2021influential citation
• Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer.

  2021influential citation
• Novel Pharmacological Targets for Pulmonary Arterial Hypertension.

  2021cites this paper
• The Role of DNMT and HDACs in the Fetal Programming of Hypertension by Glucocorticoids

  2020cites this paper
• Clinical syndrome

  2020cites this paper
• Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension

  2020cites this paper
• Novel Mutations and Decreased Expression of the Epigenetic Regulator TET2 in Pulmonary Arterial Hypertension

  2020cites this paper
• MnTBAP Reverses Pulmonary Vascular Remodeling and Improves Cardiac Function in Experimentally Induced Pulmonary Arterial Hypertension

  2020cites this paper